首页 > 市场调查报告书 > 製药

眼科药物

近视和老花眼治疗市场：按疾病类型、治疗类型和地区划分 - 市场规模、份额、展望、机会分析，2023-2030 年

市场调查报告书

商品编码

1350277

近视和老花眼治疗市场：按疾病类型、治疗类型和地区划分 - 市场规模、份额、展望、机会分析，2023-2030 年

Myopia And Presbyopia Treatment Market, by Disease Type, by Treatment Type, and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年08月04日 | 出版商:

Coherent Market Insights | 英文 220 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2023年，全球近视和老花眼市场规模将达244亿美元，预测期内（2023-2030年）复合年增长率为8.3%。

报告范围		报告详情
基准年	2022年	2023年市场规模	美国：244亿美元
之前的数据	2018年至2021年	预测期	2023-2030
预测 2023-2030 年复合年增长率：	8.30%	2030年价值预测	427亿美元

老花眼和近视是描述眼睛功能障碍的术语。近视使人难以看清远处的事物，而老花眼则使天然水晶体难以在近处和远处的物体之间转移焦点。老花眼在 40 岁至 50 岁之间出现。近视和老花眼的治疗包括手术和药物治疗。也可以使用隐形眼镜或框架眼镜进行治疗。近视和老花眼在世界各地变得越来越普遍。40岁以下族群视力丧失最常见的原因是近视，而老花眼是典型的与年龄相关的近距离聚焦能力下降。瞇眼、眼睛疲劳和头痛是近视和老花眼的症状。这些症状可以透过眼镜、隐形眼镜和屈光手术来矫正和治疗。此外，含药眼药水也是治疗近视、老花眼的新方法。由于老花眼是一种与年龄相关的视力障碍，因此老年人口的增加是推动市场成长的关键因素之一。近视是 40 岁以下视力障碍最常见的原因，而老花眼是与年龄相关的近聚焦能力的正常下降。

市场动态

主要市场参与者不断推出新产品和治疗方法、合併和收购预计将推动全球近视和老花眼治疗市场的成长。例如，2020 年 10 月 12 日，Eyenovia, Inc.（一家临床阶段的眼科生物製药公司，开发微剂量阵列打印 (MAPTM) 疗法的管道）及其全球眼保健业务 Bausch Health Companies Inc. 宣布， Bausch Health Companies Inc. 已获得在美国和加拿大开发和商业化临床显微镜列印的独家许可。此实验性阿托品製剂使用 Eyenovia, Inc. 的专有 Optejet 分配器技术进行给药。

本研究的主要特点

该研究报告对全球近视和老花眼治疗市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030年）的市场规模和復合年增长率（CAGR）。
它还强调了各个细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和批准、市场趋势、区域前景、主要参与者采取的竞争策略等的重要见解。
根据公司亮点、产品组合、主要亮点、业绩和策略等参数对全球近视和老花眼治疗市场的主要参与者进行了分析。
本研究涵盖的主要公司包括 ALCON Inc.、Bausch Health Companies Inc.、EssilorLuxottica (Essilor Ltd.)、Johnson & Johnson Vision、NIDEK CO. LTD.、Topcon Corporation、Zeimer Ophthalmic Systems AG 和 ZEISS International 等。
该报告的见解使行销人员和公司高管能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球近视和老花眼治疗市场报告迎合了该行业的各个利益相关者，如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
利害关係人可以透过用于分析全球近视和老花眼治疗市场的各种策略矩阵来促进他们的决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 24.4 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	8.30%	2030 Value Projection:	US$ 42.7 Bn

Presbyopia and myopia are terms used to describe eye dysfunction. Myopia makes it difficult to see objects in the distance, and presbyopia makes it difficult for the natural lens to shift its focus between near and far objects. Presbyopia affects people between the ages of 40 and 50. Surgery and medication are both options for treating myopia and presbyopia. Additionally, contact lenses or glasses can be used to treat these conditions. Myopia and presbyopia are becoming more common worldwide. The most frequent cause of vision impairment in people under the age of 40 is myopia (nearsightedness), whereas presbyopia is the typical age-related loss of near focusing ability. Squinting, eye strain, and headaches are signs of myopia and presbyopia. The conditions can be corrected or treated with eyeglasses, contact lenses, or refractive surgeries. Moreover, eye drops containing medication are also emerging treatments for myopia and presbyopia. Increasing geriatric population is one of the major factors driving the growth of the market, as presbyopia is an age-related visual impairment. Myopia (nearsighted) is the most common cause of impaired vision in people under the age of 40 while presbyopia is the normal loss of near focusing ability that occurs with age.

Market Dynamics

Increasing launches of new products,treatments, mergers, and acquisitions by key market players are expected to drive the global myopia and presbyopia treatment market growth. For instance, on October 12, 2020, Eyenovia, Inc., a clinical stage ophthalmic biopharmaceutical company developing a pipeline of Microdose Array Print (MAPTM) therapeutics, and Bausch Health Companies Inc., its global eye health business, announced that an affiliate of Bausch Health Companies Inc. has acquired an exclusive license in the U.S. and Canada for the development and commercialization of an investigational microscopic print. This experimental atropine formulation is administered using Eyenovia, Inc. patented Optejet dispenser technology.

Key features of the study:

This report provides an in-depth analysis of the global myopia and presbyopia treatment market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global myopia and presbyopia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include ALCON Inc., Bausch Health Companies Inc., EssilorLuxottica (Essilor Ltd.), Johnson & Johnson Vision, NIDEK CO. LTD., Topcon Corporation, Zeimer Ophthalmic Systems AG, and ZEISS International
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global myopia and presbyopia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global myopia and presbyopia treatment market

Detailed Segmentation:

Global Myopia And Presbyopia Treatment Market, By Disease Type:
- Myopia
- Presbyopia
Global Myopia And Presbyopia Treatment Market, By Treatment Type:
- Prescription Lenses
- Contact Lenses
- Surgery
- Medication
- Others
Global Myopia And Presbyopia Treatment Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
Company Profiles
- ALCON Inc.
- Bausch Health Companies Inc.
- EssilorLuxottica (Essilor Ltd.)
- Johnson & Johnson Vision
- NIDEK CO. LTD.
- Topcon Corporation
- Zeimer Ophthalmic Systems AG
- ZEISS International

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Treatment Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaboration
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Myopia And Presbyopia Treatment Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Myopia And Presbyopia Treatment Market, By Disease Type, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Myopia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Presbyopia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Global Myopia And Presbyopia Treatment Market, By Treatment Type, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Prescription Lenses
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Contact Lenses
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Myopia And Presbyopia Treatment Market, By Region, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Billion)
North Africa
Central Africa
South Africa

8. Competitive Landscape

ALCON Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bausch Health Companies Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
EssilorLuxottica (Essilor Ltd.)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Johnson & Johnson Vision
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
NIDEK CO. LTD.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Topcon Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zeimer Ophthalmic Systems AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
ZEISS International
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

9. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/价格

近视和老花眼治疗市场：按疾病类型、治疗类型和地区划分 - 市场规模、份额、展望、机会分析，2023-2030 年